We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

67 hedge funds and large institutions have $521M invested in Translate Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 7

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

12% more capital invested

Capital invested by funds: $466M → $521M (+$55.1M)

12% more funds holding

Funds holding: 60 → 67 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
67
Holders Change
+7
Holders Change %
+11.67%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
28
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$82.1M
2
CCM
Camber Capital Management
Massachusetts
+$14.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.2M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$8.66M
5
Citigroup
Citigroup
New York
+$7.85M

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$1.32M
2
Invesco
Invesco
Georgia
-$1M
3
CH
CVI Holdings
Delaware
-$852K
4
FI
Fosun International
China
-$780K
5
ECM
Endurant Capital Management
California
-$490K
Name Holding Trade Value Shares
Change 		Change in
Stake
FAM
51
Fred Alger Management
New York
$109K +$104K +11,000 New
JP Morgan Chase
52
JP Morgan Chase
New York
$107K +$26K +2,751 +34%
Morgan Stanley
53
Morgan Stanley
New York
$102K +$92.9K +9,842 +2,430%
MIG
54
McGuire Investment Group
Rhode Island
$101K +$95.8K +10,150 New
GI
55
GAMCO Investors
Connecticut
$99K +$94.4K +10,000 New
MF
56
Magnetar Financial
Illinois
$99K +$94.4K +10,000 New
Deutsche Bank
57
Deutsche Bank
Germany
$82K -$118K -12,503 -60%
Victory Capital Management
58
Victory Capital Management
Texas
$54K +$51.1K +5,408 New
Legal & General Group
59
Legal & General Group
United Kingdom
$49K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$46.8K +$13.5K +1,431 +43%
Bank of Montreal
61
Bank of Montreal
Ontario, Canada
$32K +$6.62K +701 +28%
AIP
62
Ameritas Investment Partners
Nebraska
$24K – – –
RIA
63
Realta Investment Advisors
Delaware
$22K +$20.8K +2,200 New
RWA
64
Ropes Wealth Advisors
Massachusetts
$10K +$9.44K +1,000 New
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
$6K +$5.67K +600 New
Rockefeller Capital Management
66
Rockefeller Capital Management
New York
$5K +$4.92K +521 New
Daiwa Securities Group
67
Daiwa Securities Group
Japan
$3K – – –
Invesco
68
Invesco
Georgia
– -$1M -79,539 Closed
CH
69
CVI Holdings
Delaware
– -$852K -67,464 Closed
FI
70
Fosun International
China
– -$780K -60,683 Closed
ECM
71
Endurant Capital Management
California
– -$490K -38,772 Closed
Renaissance Technologies
72
Renaissance Technologies
New York
– -$429K -34,000 Closed
BFM
73
Boothbay Fund Management
New York
– -$199K -15,790 Closed
B
74
Bailard
California
– -$167K -13,200 Closed
TRCT
75
Tower Research Capital (TRC)
New York
– -$21K -1,639 Closed
1 2
3
4

TBIO Hedge Fund Activity: Q3 2019 in Review

67 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2019, worth a combined $521M — up 12% from $466M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TBIO positions and 9 closed out — a net gain of 7 holders — while 28 added to existing stakes and 7 trimmed.

The largest buyer was Baupost Group, adding an estimated $82.1M. The largest seller was Highbridge Capital Management, cutting an estimated $1.32M.

  • 67 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2019, up from 60 in Q2 2019.
  • Funds reported $521M of Translate Bio, Inc. Common Stock stock for Q3 2019, up 12% quarter-over-quarter.
  • 16 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of +7 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q3 2019 was Baupost Group, an estimated $82.1M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2019 was Highbridge Capital Management, an estimated $1.32M sold.

Based on aggregated 13F filings for Q3 2019.